The Allergan Breast Implants were recalled because of a link between their product and an increased risk of a rare form of lymphoma called BIA-ALCL.
Yes. The FDA requested that Allergan recall both the textured implant as well as the Natrelle Biocell Tissue expanders due to increased risks of BIA-ALCL.
BIA-ALCL is not breast cancer, it is a rare form of breast implant associated (BIA) cancer called anaplastic large cell lymphoma (ALCL). A cancer of the immune system, lymphoma cells develop in the fluids and scar tissue surrounding the breast implant and in some cases can spread throughout the body.
The most common symptom of BIA-ALCL is fluid build up around the breast implant which can lead to pain, swelling and tenderness of the breast as well as lumps that could extend upward toward the armpit.
These symptoms can appear anywhere from 3 to 14 years after initial placement of the breast implant. If you suspect that you or a loved one are experiencing these symptoms as a result of the Allergan Biocell Textured breast implants, see a medical professional immediately.
According to the National Comprehensive Cancer Network (NCCN), fluid can be detected as well as lymph node swelling via an ultrasound. Both are common symptoms of BIA-ALCL.
Allergan continued selling their textured implants prior to them being recalled in Europe and Canada. The attorneys at Locks Law Firm believe that Allergan showed gross negligence and put profit over safety as they continued to sell the breast implants knowing the potential risks of developing BIA-ALCL.
